Comparison
of the benefit
of
primary
prevention
implantable
cardioverter-defibrillator therapy
in ischemic versus
nonischemic dilated cardiomyopathy
Kun Wang, MD1#; Xinyue Xu, MD1#;
Yu Qi, PhD1#; Yihai Liu, PhD2; Lina
Kang, MD1; Xiaohong Li, MD1;
Rongfang Lan, MD1; Lian Wang, MD1*;
Wei Xu,
MD1*
# These authors contributed equally.
1)Department of Cardiology,
Affiliated
Nanjing Drum Tower Hospital of Nanjing University Medical School,
Nanjing 210008, China.
2)Department of Cardiology, Nanjing Drum Tower Hospital, Clinical
College of Nanjing Medical University, Nanjing 210008, China.
This work was supported by grants from the Key Projects of Science and
Technology Development Foundation of Nanjing Department of Health
(201704003 to L. Wang) and the Six Talent Peaks Project in Jiangsu
Province (2016-WSN-157 to L. Wang).